Background {#Sec1}
==========

Patients with end-stage renal disease undergoing hemodialysis (HD) have high rates of morbidity and mortality. Cardiovascular diseases account for almost half of this mortality \[[@CR1]\]. Aortic pulse wave velocity (PWV) has been shown to be an independent predictor of cardiovascular mortality in patients with end-stage renal disease and the general population \[[@CR2]\]. Brachial-ankle pulse wave velocity (baPWV) is an accurate indicator of aortic PWV measured by intra-aortic catheter by volume-rendering \[[@CR3]\]. We have previous shown that serum aluminum level (Al) was positively associated with baPWV after correction of other known risk factors \[[@CR4]\]. Adamopoulos et al. \[[@CR5]\] analyzed the atmospheric pollution variables, including atmospheric particulate- matter (PM) concentrations and their effects on cardiovascular system by affecting arterial stiffness and central hemodynamic parameters, and found that in men, PM~10~ air pollution levels were associated with heightened amplitude of PWV. Our recently study also showed that variables of air pollution levels were associated with 2-year mortality, level of high sensitivity C-reactive protein (hsCRP), and dialysis related infections in patients undergoing peritoneal dialysis \[[@CR6]--[@CR8]\]. The purpose of this study was to access the correlation of air pollution variables and baPWV in patients undergoing HD, which had never been studied before.

Methods {#Sec2}
=======

Ethics statement {#Sec3}
----------------

This study complied with the guidelines of the Declaration of Helsinki and was approved by the Medical Ethics Committee of Chang Gung Memorial Hospital (Institutional Review Board approval number: 101-5199B), a tertiary referral center located in the northern part of Taiwan. Written informed consent for this cross-sectional and publication of these data were obtained from every patient. All data were protected securely and only available to researchers; the data were also analyzed without patients' names.

Subjects {#Sec4}
--------

One hundred and thirty eight HD patients treated at the outpatient HD center at Chang Gung Memorial Hospital in Taoyuan, Taiwan were analyzed. To diagnose peripheral arterial occlusive disease (PAOD), the ankle-brachial blood pressure index (ABPI) was developed. PAOD has a reliable and accepted marker, which is when ABPI is less than 0.9. Severe PAOD decreases baPWV due to decreased internal pressure and blood flow. Therefore, eleven patients with ABPI less than 0.9 were excluded. The analysis enrolled 127 patients. The ESRD patients were enrolled if they were on HD for more than 3 months. Medical and demographic data were collected by chart reviews and the online database at our hospital. Regular clinical survey for all patients within one month of enrollment included serum creatinine, albumin, triglyceride and cholesterol immediately before HD. Average HD session in these patients was 4 hours and three times weekly. Our HD units use water treated by reverse osmosis. Water quality, including aluminum level less than 0.01 ppm, was proved by water analysis annually. The definition of hypotension was systolic blood pressure \< 90 mmHg. The definition of intradialytic hypotension was one or more episodes of hypotension during each HD session. The definition of always hypotension was that patients had hypotension measured immediately before every HD session and throughout the entire HD session. Routine clinical workup for all patients was checked within 1 month of baPWV measurement.

Brachial-ankle pulse wave velocity (baPWV) and ABPI measurement {#Sec5}
---------------------------------------------------------------

Brachial-ankle pulse wave velocity and ABPI were measured by a Vascular Profiler 1000 (VP-1000) (Colin Corporation, Japan) as previously described in our study \[[@CR3], [@CR9]\]. Demographic data (birthday, height, weight and gender) were entered into the device. The HD patients were measured one hour before HD. After HD, baPWV does not change, or even rises. Fluid reduction by HD does not affect PWV significantly \[[@CR10]\]. After at least 10 minutes of rest, the patients were placed in a supine position, and the value of baPWV was auto-calculated and used for analysis. This profiler records baPWV, ABPI, brachial and tibial SBP, diastolic blood pressure, pulse pressure, electrocardiogram, and phonocardiogram simultaneously. The baPWV was calculated using the equation: baPWV = (D1−D2)/t, where D1 is the distance between heart and ankle, D2 is the distance between heart and brachium, and t is the transit time between brachial arterial waves and tibial arterial waves. The ABPI was calculated as the following equation: ankle systolic pressure/arm systolic pressure. The dates of baPWV measurement were between March 1^st^, 2014 to June 30^th^, 2014. Mean arterial pressure (MAP) is widely recognized to be a determinant of arterial stiffness and we used MAP adjusted baPWV for analysis. Adjustment was performed by a linear regression of the MAP and baPWV. The residual values were then added to unadjusted baPWV to form the adjusted baPWV.

Definition of normal and abnormal baPWV {#Sec6}
---------------------------------------

Because there was no previous data to define the normal range of baPWV in dialysis patients, we used the reference values stated in the study by Chuang et al. \[[@CR11]\], which showed the age and gender stratified normal reference values of baPWV derived from men and women without any of the cardiovascular risk factors for the metabolic syndrome in a community. The definition of the normal baPWV was baPWV lower than or equal to the upper limit of the reference values and the definition of abnormal baPWV was baPWV higher than the reference values.

Air quality status and analysis {#Sec7}
-------------------------------

Levels of air pollution were recorded as described in our previous study \[[@CR7]\] by a network of 26 monitoring stations near the patients' living areas in Taiwan. Data from the database on the air quality status of Taiwan Air Quality Monitoring Network were analyzed. Due to no previous survey focused on this issue, the previous average exposure of 365 days concentration of PMs, based on the date of baPWV measurement, was used for each subject. Previous 12-month average concentrations of PM with PM with an aerodynamic diameter of \<10 and \<2.5 mm (PM~10~ and PM~2.5~, respectively), sulfur dioxide (SO~2~), nitrogen dioxide (NO~2~), carbon monoxide (CO), and ozone (O~3~) were included as reference items. Air pollution levels were recorded by a network of 27 monitoring stations near or in the patients' living areas throughout Taiwan. Therefore, the average of approximately 8760 (24 × 365 = 8760) pieces of data for every monitoring station were calculated. The reference items were generally obtained from monitoring stations in the same area. If a patient lived between 2 monitoring stations, we selected the air pollutant data from the nearest station for analysis. If there is no monitoring station in a patient's living district, we selected the reference from the nearest station (\<15 km).

Statistical analysis {#Sec8}
--------------------

Mean ± standard deviation or number and percentage in parentheses, unless otherwise stated, were used to express data. Normal distribution using the Kolmogorov--Smirnov test was tested for all variables. To compare the means of continuous variables and normally distributed data, the Student's t test was used and the Mann--Whitney U test was used for non-normally distributed data. The chi-square test was used to analyze categorical data. Univariate linear regression analysis risk was used to assessed risk factors, and statistically significant variables (*P* \< 0.05) were included in a multivariate analysis by applying a forward elimination multiple linear regression. All statistical tests were 2-tailed, with P values \<0.05 being considered statistically significant. Data were analyzed using SPSS 12.0 software (SPSS, Inc., Chicago, IL).

Results {#Sec9}
=======

Subject characteristics {#Sec10}
-----------------------

A total of 127 patients from a single HD center were enrolled in this study. Table [1](#Tab1){ref-type="table"} lists the characteristics of the study subjects (mean age, 58.5 ± 9.9 years). Of all patients, 52 were male. The median baPWV was 1767.2 ± 651.5 cm/s. The median concentration of NO~2~ was 22.9 ± 3.8 ppb; CO, 0.6 ± 0.2 ppm; SO~2~, 6.9 ± 2.1 ppb; PM~10,~ 57.9 ± 5.7 mg/m^3^; PM~2.5~, 31.8 ± 2.8 mg/m3; O~3~, 25.9 ± 2.9 ppb; and NO, 10.1 ± 7.8 ppb. Because distribution of triglyceride, intact parathyroid hormone (iPTH), Al and high sensitivity C-reactive protein (hsCRP) were skewed, they were log-transformed for further analysis.Table 1Characteristics of the studied populationCharacteristicStudied patients (n = 127)Age (y)58.5 ± 9.9Male sex (%)40.9baPWV (cm/s)1767.2 ± 651.5DM (%)23.6Inradialytic hypotension (%)20.5Always hypotension (%)3.9HDF (%)16.5Hb (g/dL)10.5 ± 1.3BUN (mg/dL)64.7 ± 15.8Cr (mg/dL)10.8 ± 2.4Na (mEq/L)139.8 ± 3.1K (mEq/L)4.8 ± 0.7Calcium (mg/dL)9.8 ± 1.0Phosphorous (mg/dL)4.6 ± 1.4Calcium-phosphorous product (mg/dL)246.0 ± 16.3Alb (g/dL)4.1 ± 0.3Total cholesterol (mg/dL)185.3 ± 38.6Triglyceride (mg/dL)211.86 ± 157.37Ultrafiltration amount per dialysis session (L)2.3 ± 1.1SBP (mmHg)139.2 ± 27.0ABI1.0 ± 0.1TBI0.7 ± 0.1Body Mass Index (kg/m^2^)22.6 ± 3.5iPTH (pg/mL)191.3 ± 219.2Urea reduction rate0.8 ± 0.1Kt/V1.8 ± 0.3Net protein catabolic rate (g/day/kg body weight)1.2 ± 0.4Aluminum (ng/mL)10 ± 8Hemodialysis duration (months)72.5 ± 61.8hsCRP (mg/L)4.7 ± 6.4NO~2~ (ppb)22.9 ± 3.8CO (ppm)0.6 ± 0.2SO~2~ (ppb)6.9 ± 2.1PM~10~ (ug/m^3^)57.9 ± 5.7PM2.5 (ug/m^3^)31.8 ± 2.8O~3~ (ppb)25.9 ± 2.9NO (ppb)10.1 ± 7.8*DM* = diabetes mellitus, *HDF* = hemodiafiltration, *Hb* = hemoglobulin, *BUN* = blood urea nitrogen, *Cr* = creatinine, *K* = potassium, *SBP* = systolic blood pressure, *Alb* = albumin, *ABI* = ankle brachial index, *TBI* = tibial brachial index, *iPTH* = intact parathyroid hormone, *Kt/V* = a number used to quantify hemodialysis treatment adequacy, *Al* = aluminum, *hsCRP* = high sensitivity C reactive protein, *NO* ~*2*~ = environmental nitrogen dioxide, *CO* = environmental carbon dioxide, *SO* ~*2*~ = environmental sulfur dioxide, *PM* ~*10*~ = particulate matter with aerodynamic diameter \<10 mm, *PM* ~*2.5*~ = particulate matter with aerodynamic diameter \<2.5 mm, *O* ~*3*~ = environmental ozone, *NO* = environmental nitrogen oxide

We divided the patients into 2 groups, normal baPWV and abnormal baPWV. There were 59 patients in the normal baPWV group and 68 patients in the abnormal baPWV group. The levels of age, baPWV, SBP and hsCRP, and percentage of male, and DM were significantly higher in abnormal baPWV group. The percentage of intradialytic hypotension, and always hypotension were significantly higher in normal baPWV group (Table [2](#Tab2){ref-type="table"}).Table 2Characteristics of the normal and abnormal PWV patientsCharacteristicStudied patients (n = 127)Normal PWV (n = 59)Abnormal PWV (n = 68)*P*Age (y)56.4 ± 10.960.3 ± 8.70.032Male sex (%)30.548.50.039baPWV (cm/s)1247.2 ± 292.02218.4 ± 528.7\<0.001DM (%)10.235.30.001Inradialytic hypotension (%)34.58.8\<0.001Always hypotension (%)8.800.013HDF (%)18.614.70.551Hb (g/dL)10.5 ± 1.410.5 ± 1.30.744BUN (mg/dL)65.0 ± 15.764.5 ± 16.10.864Cr (mg/dL)11.1 ± 2.110.6 ± 2.70.223Na (mEq/L)139.6 ± 3.2140.0 ± 3.10.518K (mEq/L)4.8 ± 0.74.9 ± 0.60.511Calcium (mg/dL)9.7 ± 1.09.9 ± 1.00.276Phosphorous (mg/dL)4.6 ± 1.54.6 ± 1.40.815Calcium-phosphorous product (mg/dL)246.7 ± 16.545.4 ± 16.20.667Alb (g/dL)4.0 ± 0.24.1 ± 0.40.429Total cholesterol (mg/dL)180.5 ± 39.1189.4 ± 38.00.199Triglyceride (mg/dL)195.5 ± 130.0226.1 ± 177.50.276Ultrafiltration amount per dialysis session (L)2.5 ± 1.22.0 ± 0.90.017SBP (mmHg)129.2 ± 29.3147.9 ± 21.5\<0.001ABI1.00 ± 0.151.05 ± 0.120.055TBI0.72 ± 0.160.73 ± 0.150.545Body Mass Index (kg/m^2^)22.6 ± 3.122.5 ± 3.40.916iPTH (pg/mL)188.6 ± 201.9193.7 ± 234.60.898Urea reduction rate0.78 ± 0.060.78 ± 0.060.747Kt/V1.8 ± 0.31.8 ± 0.40.655Net protein catabolic rate (g/day/kg body weight)1.2 ± 0.41.2 ± 0.40.946Al (ng/mL)8.8 ± 5.710.4 ± 8.90.232Hemodialysis duration (months)78.7 ± 67.867.2 ± 56.00.298hsCRP (mg/L)3.4 ± 3.55.8 ± 7.70.023NO~2~ (ppb)22.9 ± 3.622.9 ± 4.00.984CO (ppm)0.63 ± 0.170.64 ± 0.220.890SO~2~ (ppb)6.7 ± 2.07.2 ± 2.10.184PM~10~ (ug/m^3^)57.2 ± 5.458. ± 5.90.226PM~2.5~ (ug/m^3^)31.6 ± 2.931.9 ± 2.80.513O~3~ (ppb)25.7 ± 2.826.0 ± 2.90.480NO (ppb)9.9 ± 4.710.4 ± 9.80.707*Normal PWV* = within the distribution of PWV, *Abnormal PWV*: higher than the distribution of PWV, *DM* = diabetes mellitus, *HDF* = hemodiafiltration, *Hb* = hemoglobulin, *BUN* = blood urea nitrogen, *Cr* = creatinine, *K* = potassium, *SBP* = systolic blood pressure, *Alb* = albumin, *ABI* = ankle brachial index, *TBI* = tibial brachial index, *iPTH* = intact parathyroid hormone, *Kt/V* = a number used to quantify hemodialysis treatment adequacy, *Al* = aluminum, *hsCRP* = high sensitivity C reactive protein, *NO* ~*2*~ = environmental nitrogen dioxide, *CO* = environmental carbon dioxide, *SO* ~*2*~ = environmental sulfur dioxide, *PM* ~*10*~ = particulate matter with aerodynamic diameter \<10 mm, *PM* ~*2.5*~ = particulate matter with aerodynamic diameter \<2.5 mm, *O* ~*3*~ = environmental ozone, *NO* = environmental nitrogen oxide

Factors associated with baPWV level in patients undergoing HD {#Sec11}
-------------------------------------------------------------

Univariate linear regression identified several clinical variables that were significantly associated with baPWV. These included fasting glucose (β = 0.272, *P* = 0.002), gender (β = 0.250, female as reference, *P* = 0.005), age (β = 0.375, *P* \< 0.001), log-transformed Al (log Al) (β = 0.201, *P* = 0.023), diabetes mellitus (β = 0.293, *P* = 0.001), intradialytic hypotension (β = −0.209, *P* = 0.019), log transformed hsCRP (log hsCRP) (β = 0.229, *P* = 0.010), SO~2~ (β = 0.208, *P* = 0.019), heart rate (β = 0.545, *P* = \<0.001) and PM~10~ (β = 0.205, *P* = 0.021). Multivariate linear regression analyses indicated that heart rate (β = 0.433, *P* \< 0.001), intradialytic hypotension (β = −0.198, *P* = 0.006), age (β = 0.193, *P* = 0.013), log Al (β = 0.144, *P* = 0.045), and PM~10~ (β = 0.150, *P* = 0.035) were positively correlated with baPWV (Table [3](#Tab3){ref-type="table"}).Table 3Linear regression analysis with baPWV as the dependent variableVariableUnstandardized coefficientsStandardized coefficients*P* valueBStd. errorBetaUnivariate Fasting glucose (mg/dL)2.7580.8730.2720.002 Gender (female as reference group)330.763114.6390.2500.005 Age (y)24.5675.4260.375\<0.001 Log Al (ng/mL)417.573181.6130.2010.023 DM447.395130.6490.2930.001 Intra-dialytic hypotension−334.493140.764−0.2090.019 Log hsCRP (mg/L)308.112116.9820.2290.010 SO~2~ (ppb)65.72227.6170.2080.019 PM~10~ (ug/m^3^)23.51210.0430.2050.021 Heart rate (/min)33.7274.6470.545\<0.001 Log triglyceride (mg/dL)60.834199.6840.0270.761 Hb (g/dL)12.61544.0660.0260.775 Alb (g/dL)−76.401179.385−0.0380.671 Total cholesterol (mg/dL)−0.3731.510−0.0220.805 Calcium (mg/dL)27.20559.1210.0410.646 Phosphorous (mg/dL)−56.56340.098−0.1250.161 Calcium-phosphorous product (mg/dL)2−5.5123.573−0.1370.125 Body Mass Index (kg/m^2^)22.99916.4600.1240.165 Urea reduction rate−1100.164999.288−0.0980.273 Kt/V−244.671172.193−0.1270.158 Net protein catabolic rate (g/day/kg body weight)−197.253156.598−0.1160.210 Hemodialysis duration (months)−1.3340.936−0.1260.156 NO~2~ (ppb)−5.59515.351−0.0330.716 CO (ppm)−163.429295.340−0.0500.581 PM~2.5~ (ug/m^3^)22.87820.4930.0990.266 O~3~ (ppb)23.47420.0800.1040.245 NO (ppb)−1.7287.433−0.0210.817 ARB/ACEi246.279173.5120.2160.158 CCB−7.177145.965−0.0040.961 Beta blocker47.806139.9340.0310.733Multivariate Heart rate (/min)26.8494.7750.433\<0.001 Intra-dialytic hypotension−317.174112.815−0.1980.006 Age (y)12.6154.9780.1930.013 Log Al (ng/mL)297.553146.6400.1440.045 PM~10~ (ug/m^3^)17.5178.2340.1500.035*DM* = diabetes mellitus, *SBP* = systolic blood pressure, *log Al* = log-transformed aluminum, log *hsCRP* = log-transformed high sensitivity C reactive protein, *Log triglyceride* = log-transformed triglyceride, *SO2* = environmental sulfur dioxide, *PM* ~*10*~ = particulate matter with aerodynamic diameter \<10 mm, *O* ~*3*~ = environmental ozone, *Hb* = hemoglobulin, *Alb* = albumin, *NO* ~*2*~ = environmental nitrogen dioxide, *CO* = environmental carbon dioxide, *PM* ~*2.5*~ = particulate matter with aerodynamic diameter \<2.5 mm, *NO* = environmental nitrogen oxide, *Kt/V* = a number used to quantify hemodialysis treatment adequacy, *ARB* = angiotensin receptor blocker, *ACEi* = angiotensin-converting-enzyme inhibitor, *CCB* = calcium channel blocker

Discussion {#Sec12}
==========

The purpose of the present study was to assess the cross sectional relations between clinical variables, ambient PM~10~ concentrations, and baPWV in HD patients. The main findings of the present study were that: PM~10~, age, Al and SBP were independently correlated with baPWV and higher concentrations of ambient PM~10~ was associated with a higher magnitude of baPWV.

This study is the first to show that environmental PM~10~ is positively associated with baPWV in HD patients. Particulate matter inhalation has been associated with acute arterial vasoconstriction in healthy adults \[[@CR12]\], disrupting systolic function \[[@CR13]\], heart rate variability \[[@CR14]\], and persistent lung inflammation and endothelial dysfunction \[[@CR15]\], factors that may increase the PWV. Automobile emissions are the most important source of PM~10~ in the urban areas, followed by crustal materials, secondary aerosols, biomass burning, industrial emissions and marine spray in Taiwan \[[@CR16]\]. Lanqrishet et al. \[[@CR17]\] showed that following exposure to diesel exhaust, N(G)-monomethyl-l-arginine (l-NMMA), a NO synthase inhibitor, caused increase in blood pressure and arterial stiffness. Graff *et a*l. \[[@CR18]\] demonstrated that after 2-hours of exposure to crustal materials, mild pulmonary inflammation, decreased tissue plasminogen activator, and decreased heart rate variability. Heo et al. \[[@CR19]\] showed that particles derived from mobile sources (i.e., gasoline and diesel emissions) and biomass burning were associated with respiratory mortality and cardiovascular mortality, respectively. The cardiovascular mortality may be due to the increased PWV as observed in our study. Ambient PM~10~ exposure had also been reported to induce considerable oxidative stress and systemic inflammation in ApoE knockout mice and contributed to the progression of atherosclerosis \[[@CR20]\]. Systemic inflammation and atherosclerosis are both predictors of increased PWV \[[@CR21]\]. Adamopoulos et al. showed no significant association between environmental variables and arterial stiffness. However, in men, the mean 5- day PM~10~ air concentration was independently associated with the augmentation pressure \[2.0 mmHg (95 % confidence interval (CI) 0.56--3.39) per 43.4 mg/m^3^\] and the aortic-pulse pressure \[2.78 mmHg (95 % CI 3.91--5.12)\] denoting a significant effect of PM on the aortic-wave reflection magnitude and central hemodynamics \[[@CR5]\]. In our study, we have demonstrated that PM~10~ was associated with baPWV, including men and women undergoing HD. The difference between our study and Adamopoulos's might be the more susceptible to the influence by air pollution in HD patients.

In our previous study, we showed that living in Taipei Basin was a risk factor predicting 2-year mortality in elderly HD patients \[[@CR22]\]. Air pollution in this crowded area may be the factor that caused this phenomenon. The present study also showed that age was also significantly correlated with baPWV. Therefore, higher PWV caused by PM~10~ might be a reason for higher 2-year mortality in HD patients living in Taipei Basin area. Our studies also demonstrated that environmental NO~2~ level was associated with 2-year mortality \[[@CR8]\] and environmental CO level was associated with the level of hsCRP in peritoneal dialysis patients \[[@CR6]\].

This study showed that Al was positively associated with baPWV and the correlation between Al and baPWV had been discussed in our previous study \[[@CR4]\]. In the study by Michael et al. \[[@CR23]\], aluminum was one of the components of PM~10~. Therefore, we calculated the correlation between serum Al level and PM~10~ and showed no significant correlation. The serum aluminum of these patients did not come from air pollution and might be due to medication, drinking water, or dissociation from aluminum containers.

Conclusion {#Sec13}
==========

In conclusion, this cross-sectional study showed that in HD patients, the environmental PM~10~ level was associated with baPWV.
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